In this abstract, multifunctional Fe3O4@SiO2@PAA-cRGD nanocomposites were designed and synthesized to load water soluble Mn-porphyrin and anticancer drug doxorubicin, which could realize both pH-responsive drug release and T1/T2 dual-mode MRI capability. In vitro cell fluorescent imagings showed that c(RGDyk)-modified nanocomposites can effectively target A549 cells. Furthermore, in vitro T1-weighted and T2-weighted MR images of A549 cells were observed. For in vivo MRI, T1 and T2 relaxation was significantly accelerated in the tumor after i.v. injection of nanocomposites. These evidences showed that the nanocomposites could be used as pH-responsive T1/T2 dual-mode contrast agent, and have the potential for the tumor-targeted MRI and drug delivery.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords